Plasma Levels of Matrix Metalloproteinases 2 and 9 in Patients with Chronic Chagas Heart Disease and Systemic Arterial Hypertension: Correlation with TGF-Beta Plasma Levels

<table class="table-group" id="tab1"><tr><td><table class="table"><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr class="thead"><td class="align_left"> </td><td class="align_center">CCHD (<i>n</i> = 19)</td><td class="align_center">CCHD-SAH (<i>n</i> = 14)</td></tr><tr><td class="thead-hr" colspan="3"><hr/></td></tr><tr><td class="align_left">Age (years)</td><td class="align_center">62 ± 2</td><td class="align_center">63 ± 2</td></tr><tr><td class="align_left">Male</td><td class="align_center">11 (57.9%)</td><td class="align_center">9 (64.2%)</td></tr><tr><td class="align_left">Female</td><td class="align_center">8 (42.1%)</td><td class="align_center">5 (35.8%)</td></tr><tr><td class="align_left">Abnormal ECG</td><td class="align_center">17 (89%)</td><td class="align_center">13 (93%)</td></tr><tr><td class="align_left">Reduced LVEF</td><td class="align_center">16 (86%)</td><td class="align_center">13 (93%)</td></tr><tr><td class="align_left">LVEF (%)</td><td class="align_center">54 ± 1.6</td><td class="align_center">53.5 ± 1.3</td></tr><tr class="table-tr"><td colspan="3"><hr class="tbody-hr"/></td></tr></table></td></tr><tr class="table-fn"><td><div>Age (mean ± standard deviation); Male: number (percentage); ECG: 12 lead-electrocardiogram; LVEF <i>=</i> left ventricular ejection fraction.<br/></div></td></tr></table>

<div>Clinical characteristics of Chagas disease patients enrolled in the study.</div>

Cardiology Research and Practice

tab1

Table 1

Table 1: Plasma Levels of Matrix Metalloproteinases 2 and 9 in Patients with Chronic Chagas Heart Disease and Systemic Arterial Hypertension: Correlation with TGF-Beta Plasma Levels 

Table 1 | Plasma Levels of Matrix Metalloproteinases 2 and 9 in Patients with Chronic Chagas Heart Disease and Systemic Arterial Hypertension: Correlation with TGF-Beta Plasma Levels 